Evidence map›Paper›PMID 27554801›Full record

ReviewDrug discovery today2017

Macrophage polarization in response to epigenetic modifiers during infection and inflammation.

Urmi Patel, Sheeja Rajasingh, Saheli Samanta, Thuy Cao, Buddhadeb Dawn, Johnson Rajasingh

Abstract readReview
In one paragraph

Review in Drug discovery today, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Alveolar macrophage-neutrophil crosstalk in acute lung injury: mechanisms, feedback loops, and therapeutic opportunities.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Urmi PatelDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Sheeja RajasinghDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Saheli SamantaDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Thuy CaoDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Buddhadeb DawnDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Johnson RajasinghDepartment of Internal Medicine, Cardiovascular Research Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: rjohnson9@kumc.edu.

Funding

Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAADI, IRFAN · 2012 to 2016
$10.9M
NIGMS NIH HHS P20 GM104936
6 · The paper itself

Abstract

Macrophages are a heterogeneous population of phagocytic cells present in all tissues. Recently, several drugs that target the epigenetic machinery have emerged as attractive molecules for treating infection and inflammation by modulating macrophages. Treatment of lipopolysaccharide (LPS)-challenged macrophages with epigenetic modifiers leads to phenotype switching. This could provide stimulatory/destructive (M1) or suppressive/protective (M2) therapeutic strategies, which are crucial in the cytokine milieu in which the macrophages reside. In this review, we provide an overview of macrophage functional diversity during various diseases, including infection, as well as the current status in the development and clinical utility of epigenetic modifiers.

Indexed as

AnimalsAzacitidineCardiovascular DiseasesDecitabineDrug Therapy, CombinationEpigenesis, GeneticHistone Deacetylase InhibitorsHumansInfectionsMacrophagesWounds and InjuriesAzacitidineDecitabineHistone Deacetylase Inhibitors

Identifiers

PMID27554801
PMCPMC5226865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.